File(s) not publicly available
Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
journal contribution
posted on 2023-05-21, 23:16 authored by Alhossain Khalafallah, Brain, TNo description available
History
Publication title
Mediterranean Journal of Hematology and Infectious DiseasesPagination
EJISSN
2035-3006Department/School
School of Health SciencesPublisher
Universita Cattolica del Sacro Cuore, Istituto di EmatologiaPlace of publication
ItalyRepository Status
- Restricted